Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 6747940, 9 pages
https://doi.org/10.1155/2017/6747940
Research Article

Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis

1Wessex Neurological Centre, University Hospital Southampton, Southampton SO21 2AS, UK
2Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK

Correspondence should be addressed to Ben Gaastra; ten.shn@artsaagb

Received 5 May 2017; Revised 10 July 2017; Accepted 25 July 2017; Published 26 September 2017

Academic Editor: Ryuichi Morishita

Copyright © 2017 Ben Gaastra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kristiansen, J. H. Graversen, C. Jacobsen et al., “Identification of the haemoglobin scavenger receptor,” Nature, vol. 409, no. 6817, pp. 198–201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Boettger, R. M. Salem, R. E. Handsaker et al., “Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels,” Nature Genetics, vol. 48, no. 4, pp. 359–366, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. C. B. Andersen, K. Stødkilde, K. L. Sæderup et al., “Haptoglobin,” Antioxidants & Redox Signaling, vol. 26, 2016. View at Publisher · View at Google Scholar
  4. M. Larsson, T.-M. Cheng, C.-Y. Chen, and J. Simon, “Unique assembly structure of human haptoglobin phenotypes 1-1, 2-1, and 2-2 and a predominant Hp 1 allele hypothesis,” in Acute Phase Proteins, S. Janciauskiene, Ed., InTech, Rijeka, 2013, Ch. 7. View at Publisher · View at Google Scholar
  5. O. Rivero-Arias, J. Wolstenholme, A. Gray et al., “The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial,” Journal of Neurology, vol. 256, no. 3, pp. 364–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Kantor, H. Bayır, D. Ren et al., “Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 120, no. 2, pp. 386–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. Iliff, H. Lee, M. Yu et al., “Brain-wide pathway for waste clearance captured by contrast-enhanced MRI,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1299–1309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Galea, G. Cruickshank, J. L. Teeling et al., “The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage,” Journal of Neurochemistry, vol. 121, no. 5, pp. 785–792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Durnford, J. Dunbar, J. Galea et al., “Haemoglobin scavenging after subarachnoid haemorrhage,” Acta Neurochirurgica Supplement, vol. 120, pp. 51–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration,” British Medical Journal, vol. 339, article b2700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Borsody, A. Burke, W. Coplin, R. Miller-Lotan, and A. Levy, “Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage,” Neurology, vol. 66, no. 5, pp. 634–640, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Leclerc, S. Blackburn, D. Neal et al., “Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 4, pp. 1155–1160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. S. B. Murthy, J. Caplan, A. P. Levy et al., “Haptoglobin 2-2 genotype is associated with cerebral salt wasting syndrome in aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 78, no. 1, pp. 71–76, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ohnishi, K. Iihara, Y. Kaku et al., “Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 4, pp. 520–526, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Cooper, D. J. Schaer, P. W. Buehler et al., “Haptoglobin binding stabilizes hemoglobin ferryl iron and the globin radical on tyrosine β145,” Antioxidants & Redox Signaling, vol. 18, no. 17, pp. 2264–2273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Pimenova, C. P. Pereira, P. Gehrig, P. W. Buehler, D. J. Schaer, and R. Zenobi, “Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin,” Journal of Proteome Research, vol. 9, no. 8, pp. 4061–4070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. B. Andersen, M. Torvund-Jensen, M. J. Nielsen et al., “Structure of the haptoglobin-haemoglobin complex,” Nature, vol. 489, no. 7416, pp. 456–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Guetta, M. Strauss, N. S. Levy, L. Fahoum, and A. P. Levy, “Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin,” Atherosclerosis, vol. 191, no. 1, pp. 48–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Philippidis, J. C. Mason, B. J. Evans et al., “Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery,” Circulation Research, vol. 94, no. 1, pp. 119–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. T. Figueiredo, P. L. Fernandez, D. S. Mourao-Sa et al., “Characterization of heme as activator of Toll-like receptor 4,” The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20221–20229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Kwon, S. K. Woo, D. B. Kurland et al., “Methemoglobin is an endogenous toll-like receptor 4 ligand-relevance to subarachnoid hemorrhage,” International Journal of Molecular Sciences, vol. 16, no. 3, pp. 5028–5046, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. D. Greenhalgh, D. Brough, E. M. Robinson, S. Girard, N. J. Rothwell, and S. M. Allan, “Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology,” Disease Models & Mechanisms, vol. 5, no. 6, pp. 823–833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Lipiski, J. W. Deuel, J. H. Baek, W. R. Engelsberger, P. W. Buehler, and D. J. Schaer, “Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity,” Antioxidants & Redox Signaling, vol. 19, no. 14, pp. 1619–1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Azarov, X. He, A. Jeffers et al., “Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin,” Nitric Oxide, vol. 18, no. 4, pp. 296–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. L. Chaichana, A. P. Levy, R. Miller-Lotan, S. Shakur, and R. J. Tamargo, “Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage,” Stroke, vol. 38, no. 12, pp. 3266–3271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Cao, M. Zheng, Y. Hua, G. Chen, R. F. Keep, and G. Xi, “Hematoma changes during clot resolution after experimental intracerebral hemorrhage,” Stroke, vol. 47, no. 6, pp. 1626–1631, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Dang, Y. Yang, G. Wu, Y. Hua, R. F. Keep, and G. Xi, “Early erythrolysis in the hematoma after experimental intracerebral hemorrhage,” Translational Stroke Research, vol. 8, no. 2, pp. 174–182, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Liu, B. Hu, S. Shao et al., “CD163/hemoglobin oxygenase-1 pathway regulates inflammation in hematoma surrounding tissues after intracerebral hemorrhage,” Journal of Stroke and Cerebrovascular Diseases, vol. 24, no. 12, pp. 2800–2809, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Liu, S. Cao, Y. Hua, R. F. Keep, Y. Huang, and G. Xi, “CD163 expression in neurons after experimental intracerebral hemorrhage,” Stroke, vol. 48, 2017. View at Publisher · View at Google Scholar
  31. V. Chamoun, A. Zeman, K. Blennow et al., “Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF,” Journal of the Neurological Sciences, vol. 182, no. 2, pp. 117–121, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. N. Diringer, “Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome?” Stroke, vol. 44, Supplement 1, no. 6, pp. S29–S30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Chen-Roetling and R. F. Regan, “Haptoglobin increases the vulnerability of CD163-expressing neurons to hemoglobin,” Journal of Neurochemistry, vol. 139, no. 4, pp. 586–595, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. T. P. Garton, Y. He, H. J. Garton, R. F. Keep, G. Xi, and J. M. Strahle, “Hemoglobin-induced neuronal degeneration in the hippocampus after neonatal intraventricular hemorrhage,” Brain Research, vol. 1635, pp. 86–94, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. G. M. Bishop and S. R. Robinson, “Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke,” Brain Research, vol. 907, no. 1-2, pp. 175–187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Hou and J. H. Zhang, “Does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome? No,” Stroke, vol. 44, Supplement 1, no. 6, pp. S34–S36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Langlois, J. Delanghe, and M. De Buyzere, “Relation between serum IgA concentration and haptoglobin type,” Clinical Chemistry, vol. 42, no. 10, pp. 1722-1723, 1996. View at Google Scholar
  38. H. Louagie, J. Delanghe, I. Desombere, M. De Buyzere, P. Hauser, and G. Leroux-Roels, “Haptoglobin polymorphism and the immune response after hepatitis B vaccination,” Vaccine, vol. 11, no. 12, pp. 1188–1190, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Márquez, C. Shen, I. Cleynen et al., “Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis,” Gut, vol. 61, no. 4, pp. 528–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Bjornsson, H. Helgason, G. Halldorsson et al., “A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease,” Human Molecular Genetics, vol. 26, no. 12, pp. 2364–2376, 2017. View at Publisher · View at Google Scholar
  41. M. Soejima, N. Sagata, N. Komatsu et al., “Genetic factors associated with serum haptoglobin level in a Japanese population,” Clinica Chimica Acta, vol. 433, pp. 54–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. K. U. Park, J. Song, and J. Q. Kim, “Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans,” Journal of Clinical Pathology, vol. 57, no. 10, pp. 1094-1095, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. I. Kasvosve, Z. A. Gomo, I. T. Gangaidzo et al., “Reference range of serum haptoglobin is haptoglobin phenotype-dependent in blacks,” Clinica Chimica Acta, vol. 296, no. 1-2, pp. 163–170, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. F. J. Fowkes, H. Imrie, F. Migot-Nabias et al., “Association of haptoglobin levels with age, parasite density, and haptoglobin genotype in a malaria-endemic area of Gabon,” The American Journal of Tropical Medicine and Hygiene, vol. 74, no. 1, pp. 26–30, 2006. View at Google Scholar
  45. H. Imrie, F. J. Fowkes, P. Michon et al., “Haptoglobin levels are associated with haptoglobin genotype and alpha+-thalassemia in a malaria-endemic area,” The American Journal of Tropical Medicine and Hygiene, vol. 74, no. 6, pp. 965–971, 2006. View at Google Scholar
  46. M. Melamed-Frank, O. Lache, B. I. Enav et al., “Structure-function analysis of the antioxidant properties of haptoglobin,” Blood, vol. 98, no. 13, pp. 3693–3698, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Asleh, J. Guetta, S. Kalet-Litman, R. Miller-Lotan, and A. P. Levy, “Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo,” Circulation Research, vol. 96, no. 4, pp. 435–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. L. Mollan, Y. Jia, S. Banerjee et al., “Redox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobin,” Free Radical Biology and Medicine, vol. 69, pp. 265–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. V. V. Bamm, V. A. Tsemakhovich, M. Shaklai, and N. Shaklai, “Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL,” Biochemistry, vol. 43, no. 13, pp. 3899–3906, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Asleh, S. Marsh, M. Shilkrut et al., “Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease,” Circulation Research, vol. 92, no. 11, pp. 1193–1200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Na, J. Ouyang, Y. E. Taes, and J. R. Delanghe, “Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type,” Clinical Chemistry, vol. 51, no. 9, pp. 1754-1755, 2005. View at Publisher · View at Google Scholar · View at Scopus